BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie Y, Xie F, Zhang L, Zhou X, Huang J, Wang F, Jin J, Zhang L, Zeng L, Zhou F. Targeted Anti-Tumor Immunotherapy Using Tumor Infiltrating Cells. Adv Sci (Weinh) 2021;8:e2101672. [PMID: 34658167 DOI: 10.1002/advs.202101672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hassanian H, Asadzadeh Z, Baghbanzadeh A, Derakhshani A, Dufour A, Rostami Khosroshahi N, Najafi S, Brunetti O, Silvestris N, Baradaran B. The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment. Front Immunol 2022;13:938063. [DOI: 10.3389/fimmu.2022.938063] [Reference Citation Analysis]
2 Hu W, Liu D, Li R, Qian H, Qiu W, Ye Q, Kong F. Comprehensive Analysis of TRIM Family Genes in Hepatitis Virus B-Related Hepatoma Carcinoma. Front Genet 2022;13:913743. [DOI: 10.3389/fgene.2022.913743] [Reference Citation Analysis]
3 You W, Ma F, Zhang Z, Yan J. Turning a Targeting β-Catenin/Bcl9 Peptide Inhibitor into a GdOF@Au Core/Shell Nanoflower for Enhancing Immune Response to Cancer Therapy in Combination with Immune Checkpoint Inhibitors. Pharmaceutics 2022;14:1306. [PMID: 35745877 DOI: 10.3390/pharmaceutics14061306] [Reference Citation Analysis]
4 Wang W, Guo MN, Li N, Pang DQ, Wu JH. Glutamine deprivation impairs function of infiltrating CD8+ T cells in hepatocellular carcinoma by inducing mitochondrial damage and apoptosis. World J Gastrointest Oncol 2022; 14(6): 1124-1140 [DOI: 10.4251/wjgo.v14.i6.1124] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lai G, Li K, Deng J, Liu H, Xie B, Zhong X, Srinivasan K. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors. Journal of Healthcare Engineering 2022;2022:1-17. [DOI: 10.1155/2022/8704127] [Reference Citation Analysis]
6 Sun F, Lian Y, Wang J, Hu L, Luo J, Yu J, Wang J. KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/4829697] [Reference Citation Analysis]
7 Xing J, Chen M, Han Y. . MBE 2022;19:5905-24. [DOI: 10.3934/mbe.2022276] [Reference Citation Analysis]